Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982

Online
ISSN
1437-4331
See all formats and pricing
In This Section
Volume 42, Issue 10 (Oct 2004)

Issues

Time course of systemic markers of inflammation in patients presenting with acute coronary syndromes

Martina Brueckmann
  • First Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim, Germany
/ Thomas Bertsch
  • Institute of Clinical Chemistry and Laboratory Medicine, Clinic Nuremberg, Nuremberg, Germany and Institute of Clinical Chemistry and Institute of Clinical Chemistry, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim, Germany
/ Siegfried Lang
  • First Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim, Germany
/ Tim Sueselbeck
  • First Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim, Germany
/ Christian Wolpert
  • First Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim, Germany
/ Jens J. Kaden
  • First Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim, Germany
/ Carlos Jaramillo
  • First Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim, Germany
/ Guenter Huhle
  • First Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim; Eli Lilly and Company, Lilly Germany GmbH, Bad Homburg, Germany
/ Martin Borggrefe
  • First Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim, Germany
/ Karl K. Haase
  • First Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Mannheim, Germany
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2004.232

Abstract

Inflammation within coronary plaques may cause an acute coronary syndrome by promoting rupture and erosion. It was the aim of this study to examine whether markers of inflammation derive from a cardiac or extracardiac source and how their levels develop over time.

Blood samples were taken from patients with acute coronary syndromes (ACS) with proven atherosclerotic lesion(s) of the left coronary artery (n = 13) and from control patients without coronary artery disease (n = 13). Blood was taken from the femoral vein and the coronary sinus vein before and after coronary angioplasty (day 0) and on days 1 and 120.

Levels of tumor necrosis factor-α (TNF-α), interleukin- 6 (IL-6), interleukin-1-receptor antagonist (IL-1 ra) and soluble CD40 ligand (sCD40L) were higher in ACS patients as compared to controls and remained elevated up to day 120. In the long-term time course these markers of inflammation and plaque remodeling slightly decreased in ACS patients. There were no statistically significant differences detectable in the levels of TNF-α, IL-6, IL-1 β, IL-10, IL-1 ra, sCD40L and monocyte chemoattractant protein-1 (MCP-1) in the blood of ACS patients taken from a cardiac source as compared to an extracardiac source (coronary sinus vs. femoral vein).

This study demonstrates the importance of a systemic inflammatory condition in patients with ACS, in whom markers of inflammation are increased as compared to controls. During long-term follow-up the pro-inflammatory activity remains elevated in ACS patients, supporting the concept of a systemic rather than a local vascular inflammation contributing to the development of atherosclerosis.

Keywords: acute coronary syndrome; coronary sinus; inflammation; time course

References

  • 1

    Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91:2844–50.

  • 2

    Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM. Identification of 92-kDa gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation 1995; 91:2125–31.

  • 3

    Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94:2493–503.

  • 4

    Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O’Neill WW. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000; 343:915–22.

  • 5

    Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997; 17:1121–7.

  • 6

    Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997; 349:462–6.

  • 7

    Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, et al. The prognostic value of C-reactive protein and serum amyloid, a protein in severe unstable angina. N Engl J Med 1994; 331:417–24.

  • 8

    Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101:1767–72.

  • 9

    Garcia-Moll X, Coccolo F, Cole D, Kaski JC. Serum neopterin and complex stenosis morphology in patients with unstable angina. J Am Coll Cardiol 2000; 35:956–62.

  • 10

    Zairis MN, Papadaki OA, Manousakis SJ, Thoma MA, Beldekos DJ, Olympios CD, et al. C-reactive protein and multiple complex coronary artery plaques in patients with primary unstable angina. Atherosclerosis 2002; 164:355–9.

  • 11

    Enbergs A, Bürger R, Reinecke H, Borggrefe M, Breithardt G, Kerber S. Prevalence of coronary artery disease in a general population without suspicion of coronary artery disease: angiographic analysis of subjects aged 40 to 70 years referred for catheter ablation therapy. Eur Heart J 2000; 21:45–52.

  • 12

    Hamm CW, Bertrand M, Braunwald E. Acute coronary syndrome without ST elevation: implementation of new guidelines. Lancet 2001; 358:1533–8.

  • 13

    Buffon A, Biasucci LM, Liuzzo G, D’Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 2002; 347:5–12.

  • 14

    Spagnoli LG, Bonanno E, Mauriello A, Palmieri G, Partenzi A, Sangiorgi G, et al. Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. J Am Coll Cardiol 2002; 40:1579–88.

  • 15

    Schönbeck U, Libby P. CD40 signaling and plaque instability. Circ Res 2001; 89:1092–103.

  • 16

    Graf D, Korthauer U, Mages HW, Senger G, Kroczek RA. Cloning of TRAP, a ligand for CD40 on human T cells. Eur J Immunol 1992; 22:3191–4. [Crossref]

  • 17

    Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F, et al. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 1999; 99:2079–84.

  • 18

    Biasucci LM, Luizzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999; 99:855–60.

  • 19

    Berk BC, Weintraub WS, Alexander RW. Elevation of Creactive protein in active coronary artery disease. Am J Cardiol 1990; 65:168–72.

  • 20

    De Beer FC, Hind CR, Fox KM, Allan RM, Maseri A, Pepys MB. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J 1982; 47:239–43.

  • 21

    Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347:1557–65.

  • 22

    Burke AP, Tracy RP, Kolodgie F, Malcolm GT, Zieske A, Kutys R, et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002; 105:2019–23.

  • 23

    Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. J Am Med Assoc 2001; 286:2107–13.

  • 24

    Fiotti N, Giansante C, Ponte E, Delbello C, Calabrese S, Zacchi T, et al. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis 1999; 145:51–60.

  • 25

    Biasucci LM, Liuzzo G, Angiolillo DJ, Sperti G, Maseri A. Inflammation and acute coronary syndromes. Herz 2000; 2:108–12. [Crossref]

  • 26

    Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998; 16:111–35.

  • 27

    Sukhova GK, Schönbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999; 99:2503–9.

  • 28

    Peng DQ, Zhao SP, Li YF, Li Y, Zhou HN. Elevated soluble CD40 ligand is related to the endothelial adhesion molecules in patients with acute coronary syndromes. Clin Chim Acta 2002; 319:19–26.

  • 29

    Heeschen C, Dimmeler S, Hamm C, van den Brand MJ, Boersma E, Zeiher AM, et al. for the Capture Study Investigators. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003; 348:1104–11.

  • 30

    Varo N, de Lemos JA, Libby P, Morrow DA, Murphy SA, Nuzzo R, et al. Soluble CD40L – risk prediction after acute coronary syndromes. Circulation 2003; 108:1049–52.

About the article

Corresponding author. Martina Brueckmann, MD, First Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany. Phone/Fax: +49-621-383-2875, E-mail:


Received: 2004-05-28

Accepted: 2004-08-23

Published Online: 2005-06-01

Published in Print: 2004-10-01



Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2004.232. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Rumi J. Jaumdally, Chetan Varma, Andrew D. Blann, Robert J. MacFadyen, and Gregory Y.H. Lip
Chest, 2007, Volume 132, Number 5, Page 1532
[2]
H. Meng, M. Zhang, P. Chen, Z.-M. Wang, B. Chen, and Z. Yang
Acta Biochimica et Biophysica Sinica, 2014, Volume 46, Number 2, Page 161
[3]
Shu Wang, Bradley Miller, Nirupa R. Matthan, Zeynep Goktas, Dayong Wu, Debra B. Reed, Xiangling Yin, Paula Grammas, Naima Moustaid-Moussa, Chwan-Li Shen, and Alice H. Lichtenstein
Nutrition Research, 2013, Volume 33, Number 12, Page 1072
[4]
Ute Wilbert-Lampen, Thomas Nickel, David Leistner, Denise Güthlin, Tomas Matis, Christoph Völker, Sebastian Sper, Helmut Küchenhoff, Stefan Kääb, and Gerhard Steinbeck
Journal of the American College of Cardiology, 2010, Volume 55, Number 7, Page 637
[5]
Maurizio Bossola, Fausto Rosa, Luigi Tazza, Amalia Curtis, Simona Costanzo, Carlo Vulpio, and Licia Iacoviello
Hemodialysis International, 2011, Page n/a
[6]
Petra H. Wirtz, Ulrike Ehlert, Luljeta Emini, and Tobias Suter
Psychoneuroendocrinology, 2008, Volume 33, Number 8, Page 1102
[8]
Jeong-Han Lee, Chan-Ny Park, and Rae-Kil Park
Journal of Life Science, 2008, Volume 18, Number 4, Page 542
[9]
Felicia Antohe
Archives Of Physiology And Biochemistry, 2006, Volume 112, Number 4-5, Page 245
[10]
Thomas Bertsch, Tim Sueselbeck, Christian Wolpert, Ursula Hoffmann, Jens J. Kaden, Karl K. Haase, Martin Borggrefe, and Martina Brueckmann
Clinical Chemical Laboratory Medicine, 2005, Volume 43, Number 6
[11]
NourEddine ElMokhtari, Sascha Zschernitz, Susanne Sebens, Gunhild Simon-Herrmann, and Dietmar Krüger
Journal of Thrombosis and Thrombolysis, 2010, Volume 30, Number 4, Page 391
[12]
Carlo Giansante, Nicola Fiotti, Antonio Di Chiara, Nicola Altamura, Stella Wasserman, Paolo Fioretti, and Gianfranco Guarnieri
Journal of Cardiovascular Medicine, 2007, Volume 8, Number 8, Page 602
[13]
Shu Wang, Dayong Wu, Nirupa R. Matthan, Stefania Lamon-Fava, Jaime L. Lecker, and Alice H. Lichtenstein
Lipids, 2010, Volume 45, Number 8, Page 701
[14]
Simona Kirbiš, Urška D. Breskvar, Mišo Šabovič, Igor Zupan, and Andreja Sinkovič
Wiener klinische Wochenschrift, 2010, Volume 122, Number S2, Page 31
[15]
Peter H. Jones and John A. Farmer
Current Atherosclerosis Reports, 2008, Volume 10, Number 2, Page 142
[17]
Dilyara G. Yanbaeva, Mieke A. Dentener, Eva C. Creutzberg, and Emiel F. M. Wouters
COPD: Journal of Chronic Obstructive Pulmonary Disease, 2006, Volume 3, Number 1, Page 51

Comments (0)

Please log in or register to comment.
Log in